Punctate Inner Choroidopathy: A Systematic Review
Medical hypothesis discovery and innovation in ophthalmology,
Vol. 3 No. 3 (2014),
1 September 2014
,
Page 76-82
Abstract
This article reviews clinically relevant data regarding punctate inner choroidopathy, mainly the various treatment options. Punctate inner choroidopathy is an uncommon, inflammatory, multifocal chorioretinopathy affecting mostly young myopic women. It is characterized by the presence of multiple, small, well-defined, yellow-white fundus lesions, in the absence of intraocular inflammation. We describe etiology, clinical findings and ancillary tests that help in the diagnosis and detection of complications. Treatment options that have been used to manage patients with PIC and CNV include immunosuppressants, corticoids, laser photocoagulation, photodynamic therapy, intravitreal anti-VEGF agents and submacular surgery.References
Watzke RC, Packer AJ, Folk JC, Benson WE, Burgess D, Ober RR. Punctate inner choroidopathy. Am J Ophthalmol. 1984 Nov;98(5):572-84. PMID: 6208783.
American Academy of Ophtalmology, The Eye M.D. Association: Focal and Diffuse Choroidal and Retinal Inflammation; in Basic and Clinical Science Course, section 12: Retina and Vitreous. Leo; 2011-2012.
Channa R, Ibrahim M, Sepah Y, Turkcuoglu P, Lee JH, Khwaja A, Hatef E, Bittencourt M, Heo J, Do DV, Nguyen QD. Characterization of macular lesions in punctate inner choroidopathy with spectral domain optical coherence tomography. J Ophthalmic Inflamm Infect. 2012 Sep;2(3):113-20. PMID: 22210152
Gerstenblith AT, Thorne JE, Sobrin L, Do DV, Shah SM, Foster CS, Jabs DA, Nguyen QD: Punctate inner choroidopathy: a survey analysis of 77 persons. Ophthalmology. 2007 Jun;114(6):1201-4. PMID: 17434588
Olsen TW, Capone A, Sternberg P Jr, Grossniklaus HE, Martin DF, Aaberg TM Sr. Subfoveal choroidal neovascularization in punctate inner choroidopathy. Surgical management and pathologic findings. Ophthalmology. 1996 Dec;103(12):2061-9. PMID: 9003340
Brouzas D, Charakidas A, Rotsos T, Moschos MM, Loukianou H, Koutsandrea C, Ladas I, Baltatzis S. Choroidal neovascularization due to punctuate inner choroidopathy: long-term follow-up and review of literature. Clin Ophthalmol. 2010 Aug 9;4:871-6. PMID: 20714365
Turkcuoglu P, Chang PY, Rentiya ZS, Channa R, Ibrahim M, Hatef E, Sophie R, Sadaka A, Wang J, Sepah YJ, Do DV, Foster CS, Nguyen QD. Mycophenolate Mofetil and Fundus Autofluorescence in the Management of Recurrent Punctate Inner Choroidopathy. Ocul Immunol Inflamm. 2011 Aug;19(4):286-92. PMID: 21770809
Levy J, Shneck M, Klemperer I, Lifshitz T: Punctate inner choroidopathy: resolution after oral steroid treatment and review of the literature. Can J Ophthalmol. Oct 2005;40(5):605-8. PMID: 16391624
Chan WM, Lai TY, Lau TT, Lee VY, Liu DT, Lam DS. Combined photodynamic therapy and intravitreal triamcinolone for choroidal neovascularization secondary to punctate inner choroidopathy or of idiopathic origin: one-year results of a prospective series. Retina. 2008 Jan;28(1):71-80. PMID: 18185141
Valverde MegÃas A, Arriola Villalobos P, Reche Frutos J, Donate López J, Calvo González C, GarcÃa Feijoo J. Intravitreal ranibizumab (Lucentis®) in the treatment of choroidal neovascular membrane secondary to punctate inner choroidopathy. Arch Soc Esp Oftalmol. 2010 Apr;85(4):149-52. PMID: 20858403
Mangat SS, Ramasamy B, Prasad S, Walters G, Mohammed M, Mckibbin M. Resolution of choroidal neovascularization secondary to punctate inner choroidopathy (PIC) with intravitreal anti-VEGF agents: a case series. Semin Ophthalmol. 2011 Jan;26(1):1-3. PMID: 21275596
Chan WM, Lai TY, Liu DT, Lam DS. Intravitreal bevacizumab (avastin) for choroidal neovascularization secondary to central serous chorioretinopathy, secondary to punctate inner choroidopathy, or of idiopathic origin. Am J Ophthalmol. 2007 Jun;143(6):977-983. PMID: 17459318
Jampol LM, Becker KG. White spot syndromes of the retina: a hypothesis based on the common genetic hypothesis of autoimmune/inflammatory disease. Am J Ophthalmol 2003;135:376–9. PMID: 12614757
Hirooka K, Saito W, Hashimoto Y, Saito M, Ishida S. Increased macular choroidal blood flow velocity and decreased choroidal thickness with regression of punctate inner choroidopathy. BMC Ophthalmol. 2014 May 28;14:73. PMID: 24885365
Essex RW, Wong J, Fraser-Bell S, Sandbach J, Tufail A, Bird AC, Dowler J. Punctate inner choroidopathy: clinical features and outcomes. Arch Ophthalmol. 2010 Aug;128(8):982-7. PMID: 20696997
Brown J, Folk JC, Reddy CV, Kimura AE. Visual prognosis of multifocal choroiditis, punctate inner choroidopathy, and the diffuse subretinal fibrosis syndrome. Ophthalmology. 1996;103:1100-5. PMID: 8684800
Campos J, Campos A, Beselga D, Mendes S, Neves A, Sousa JP. Punctate Inner Choroidopathy: A Clinical Case Report. Case Rep Ophthalmol. 2013 Sep 28;4(3):155-9. PMID: 24163685
Amer R, Lois N. Punctate Inner Choroidopathy. Surv Ophthalmol. 2011 Jan-Feb;56(1):36-53. PMID: 21056447
Patel KH, Birnbaum AD, Tessler HH, Goldstein DA. Presentation and outcome of patients with punctate inner choroidopathy at a tertiary referral center. Retina. 2011;31(7):1387-91. PMID: 21478811
Zarranz-Ventura J, Sim DA, Keane PA, Patel PJ, Westcott MC, Lee RW, Tufail A, Pavesio CE. Characterization of Punctate Inner Choroidopathy Using Enhanced DepthImaging Optical Coherence Tomography. Ophthalmology. 2014 Sep;121(9):1790-7. PMID: 24856311
Tiffin PA, Maini R, Roxburgh ST, Ellingford A. Indocyanine green angiography in a case of punctate inner choroidopathy. Br J Ophthalmol. 2002;80(1):90-1. PMID: 8664243
Flaxel CJ, Owens SL, Mulholland B, Schwartz SD, Gregor ZJ. The use of corticosteroids for choroidal neovascularisation in young patients. Eye (Lond). 1998;12 ( Pt 2):266-72. PMID: 9683952
Brueggeman RM, Noffke AS, Jampol L. Resolution of punctate inner choroidopathy lesions with oral prednisone therapy. Arch Ophthalmol 2002;120(7):996. PMID: 12096982
Leung A, Weisbrod D, Schwartz C. Intravitreal ranibizumab in the treatment of choroidal neovascular membrane secondary to punctate inner choroidopathy. Can J Ophthalmol. 2010 Jun;45(3):300-1. PMID: 20379284
Menezo V, Cuthbertson F, Downes SM. Positive responseto intravitreal ranibizumab in the treatment of choroidalneovascularization secondary to punctate innerchoroidopathy. Retina. 2010 Oct;30(9):1400-4. PMID: 20224465
Rouvas A, Petrou P, Douvali M, Ntouraki A, Vergados I, Georgalas I, Markomichelakis N. Intravitreal ranibizumab for the treatment of inflammatory choroidal neovascularization. Retina. 2011 May;31(5):871-9. PMID: 21358461
Zhang H, Liu ZL, Sun P, Gu F. Intravitreal bevacizumab as primary treatment of choroidal neovascularization secondary to punctate inner choroidopathy: results of a 1-year prospective trial. Retina. 2012 Jun;32(6):1106-13. PMID: 22481479
Jiménez B, Pinilla I, Cristóbal JA, MÃnguez E, Pérez D, Cruz N, Peiro C. Intravitreal ranibizumab in the treatment of subretinal neovascularization in a case of punctate inner choroidopathy. Arch Soc Esp Oftalmol. 2014 Mar;89(3):130-2. PMID: 24269388
Postelmans L, Pasteels B, Coquelet P, Caspers L, Verougstraete C, Leys A, Wirix M, Mauget-Faÿsse M, Quanranta M, Snyers B, Smets E. Photodynamic therapy for subfoveal classic choroidal neovascularization related to punctate inner choroidopathy (PIC) or presumed ocular histoplasmosis-like syndrome (POHS-like). Ocul Immunol Inflamm. 2005 Sep-Oct;13(5):361-6. PMID: 16419421
Coco RM, de Souza CF, Sanabria MR. Photodynamic therapy for subfoveal and juxtafoveal choroidal neovascularization associated with punctate inner choroidopathy. Ocul Immunol Inflamm. 2007 Jan-Feb;15(1):27-9. PMID: 17365803
- Abstract Viewed: 2726 times
- Full Text PDF Downloaded: 2923 times